News

Green Griffith Marks Fourth Anniversary

Built on the premise of offering sophisticated legal counsel, combined with a personal approach based on the belief that…
Read More >

Super Lawyers Recognizes Green Griffith 2019 Award-Winning Attorneys

It is particularly noteworthy that our award-winning partners have been on the Super Lawyers list for multiple years, hi…
Read More >

U.S. News Ranks Green Griffith as One of Nation’s Best

Green Griffith has received the following rankings in the 2019 edition of U.S. News – Best Lawyers® “…
Read More >

Federal Circuit: USPTO Incorrectly Calculates Patent Term Adjustment (PTA)

In a January 23, 2019, opinion, the Federal Circuit determined that the U.S. Patent and Trademark Office (USPTO) imprope…
Read More >

Chris Griffith Speaks at 9th Asia Pharma R&D Leaders Conference

This event provided a strategic platform for companies, academia and other stakeholders in the Asia biopharma industry t…
Read More >

US Supreme Court Decides that a “Secret” Sale or Offer for Sale of a Claimed Invention is Invalidating Prior Art Under the AIA

The US Supreme Court in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., determined that because Congress reta…
Read More >

Hatch-Waxman Integrity Act Introduced in US House and Senate

Members of the US House and Senate, on December 11, 2018, jointly introduced the Hatch-Waxman Integrity Act of 2018. Cop…
Read More >

Caryn Borg-Breen to Speak at Chicago Women in Law Conference

Green Griffith is pleased to announce that founding partner, Caryn Borg-Breen, will participate in a panel discussion ex…
Read More >

Chris Griffith Speaks at 3rd Annual China Pharma IP Summit

This event focused on a variety of IP topics pertinent to pharma stakeholders located in Asia, including pharma-related …
Read More >

District Court Finds Safe Harbor Defense Does Not Apply to Continued Process Verification Program Undertaken by Biosimilar Applicant

The Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) creates an artificial act of infringe…
Read More >

Burden to Rebut Obviousness in IPR Proceedings May Properly Be Placed on Patentee in the Context of Overlapping Prior Art Numerical Ranges

Under Federal Circuit precedent, a presumption of obviousness typically exists when numerical ranges recited in a claim …
Read More >

Federal Circuit Confirms Standing to Appeal IPR Decision in Absence of Infringement Lawsuit

In a September 17, 2018, decision (E.I. DuPont de Nemours v. Synvina, Appeal No. 2017-1977, available here), the Federal…
Read More >